Neurizon Therapeutics is free to advance the next clinical trial of its candidate to treat amyotrophic lateral sclerosis (ALS).

Uncertainty is ubiquitous in the practice of medicine. This review characterizes clinical uncertainty and shows how teachers ...

The deal focuses on ICT01, a monoclonal antibody being tested in acute myeloid leukemia. ImCheck is also developing assets in ...

The health secretary wrote to GPs asking them to ensure learning disability registers are up to date and annual health checks ...

Experts emphasize that there has been no real change in the benefits or risks of the vaccines, which are quite safe and offer ...

In this vein, four drug developers today delivered trial updates that would never move the market in isolation. But they are crucial milestones towards the ultimate destination. The clinicians can ...

In September 2025, the Russian Federal Medical and Biological Agency announced that a Russian cancer vaccine had passed preclinical trials with promising results. Following this announcement, posts ...

Upslope Capital Management, an investment management company, released its third-quarter investor letter. A copy of the ...

Meanwhile, fewer than half of adults ages 18-34 recognize high cholesterol, obesity, high blood pressure and lack of physical ...

The agency applied the brakes on January 17, pending "further clarification and additional information". The FDA later said it wanted further animal exposure data to assess safety aspects. But it didn ...

As the majority of women admit to suffering brain fog during menopause, isn't it high time we finally closed in on a solution ...

A substantial body of evidence supports the safety of the COVID-19 vaccines during pregnancy, contrary to the suggestions of ...